Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121825252 | 12182525 | 2 | F | 201602 | 20160920 | 20160316 | 20160926 | EXP | FR-AFSSAPS-LM20160220 | FR-GLAXOSMITHKLINE-FR2016GSK035311 | GLAXOSMITHKLINE | 66.68 | YR | M | Y | 0.00000 | 20160926 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121825252 | 12182525 | 1 | PS | Zelitrex | VALACYCLOVIR HYDROCHLORIDE | 1 | UNK | U | 20487 | ||||||||||
121825252 | 12182525 | 2 | SS | ALKERAN | MELPHALAN | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
121825252 | 12182525 | 3 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | UNK | U | 0 | ||||||||||
121825252 | 12182525 | 4 | SS | Cortancyl | PREDNISONE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
121825252 | 12182525 | 5 | SS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | ||||||||
121825252 | 12182525 | 6 | SS | INNOHEP | TINZAPARIN SODIUM | 1 | Subcutaneous | UNK | U | 0 | |||||||||
121825252 | 12182525 | 7 | SS | Carfilzomib | CARFILZOMIB | 1 | Intravenous (not otherwise specified) | 140 MG, CYC | U | 0 | 140 | MG | |||||||
121825252 | 12182525 | 8 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
121825252 | 12182525 | 9 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
121825252 | 12182525 | 10 | C | DEBRIDAT | TRIMEBUTINE MALEATE | 1 | UNK | 0 | |||||||||||
121825252 | 12182525 | 11 | C | DESLORATADINE. | DESLORATADINE | 1 | UNK | 0 | |||||||||||
121825252 | 12182525 | 12 | C | PERMIXON | SAW PALMETTO | 1 | UNK | 0 | |||||||||||
121825252 | 12182525 | 13 | C | COVERAM | AMLODIPINEPERINDOPRIL | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121825252 | 12182525 | 1 | Prophylaxis |
121825252 | 12182525 | 2 | Plasma cell myeloma |
121825252 | 12182525 | 3 | Product used for unknown indication |
121825252 | 12182525 | 4 | Product used for unknown indication |
121825252 | 12182525 | 5 | Product used for unknown indication |
121825252 | 12182525 | 6 | Product used for unknown indication |
121825252 | 12182525 | 7 | Plasma cell myeloma |
121825252 | 12182525 | 8 | Product used for unknown indication |
121825252 | 12182525 | 9 | Product used for unknown indication |
121825252 | 12182525 | 10 | Product used for unknown indication |
121825252 | 12182525 | 11 | Product used for unknown indication |
121825252 | 12182525 | 12 | Product used for unknown indication |
121825252 | 12182525 | 13 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121825252 | 12182525 | OT |
121825252 | 12182525 | DE |
121825252 | 12182525 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121825252 | 12182525 | Cardiac failure | |
121825252 | 12182525 | Congestive cardiomyopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121825252 | 12182525 | 1 | 20150708 | 0 | ||
121825252 | 12182525 | 2 | 20160203 | 20160206 | 0 | |
121825252 | 12182525 | 3 | 20150708 | 0 | ||
121825252 | 12182525 | 4 | 20160203 | 0 | ||
121825252 | 12182525 | 5 | 20150708 | 0 | ||
121825252 | 12182525 | 6 | 201507 | 0 | ||
121825252 | 12182525 | 7 | 20160203 | 0 |